Established with the vision to create indigenous, scalable genomic solutions, Decipher has built a state-of-the-art facility equipped with platforms for Sanger sequencing, genotyping, next-generation sequencing (NGS), microarrays, PCR/qPCR, and custom assay development. The company’s offerings cater to diverse sectors—including clinical diagnostics, agriculture, animal health, and research—with a strong emphasis on cost-effectiveness, regulatory compliance, and scientific excellence.

Aligned with national priorities like the ‘Make in India’ initiative and committed to building quality infrastructure, Decipher continues to foster innovation, collaboration, and a legacy of impactful service delivery across India’s genomic landscape.

Today, Decipher Genomics stands at the forefront of India’s biotech ecosystem—delivering services to researchers, agro-veterinary specialists, and forensic experts across disciplines. Our solutions extend from disease diagnostics, Predictive Genomics and carrier screening to animal genetics, forensic investigations, and kit manufacturing, aligned with regulatory frameworks and scientific best practices.

Backed by ISO, NABL, GMP and GLP-compliant processes (in progress), and actively contributing to the Make in India movement, Decipher is not just building a genomics company—it’s building a legacy of impact that bridges science, society, and sustainability.